Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SLC35E1 Activators

SLC35E1 include a variety of nucleotide sugars and related compounds that are essential for the glycosylation processes within cells. The activation process of SLC35E1 involves the transport of these nucleotide sugars across membranes to facilitate glycosylation in the Golgi apparatus. For instance, UDP-Glucose and UDP-Galactose are direct substrates for glycosyltransferases, thus the presence of these sugars can activate SLC35E1 to enhance their transport and meet the glycosylation demand. Similarly, CMP-Neu5Ac and GDP-Mannose are also substrates for respective transferases involved in glycosylation, and an increase in their intracellular levels necessitates the transport activity of SLC35E1. This ensures an efficient supply of these sugars to the enzymatic sites where glycosylation occurs.

SLC35E1 activation is also associated with the transport of other nucleotide sugars like UDP-N-Acetylglucosamine and UDP-N-Acetylgalactosamine, which are crucial for the synthesis of glycoproteins. The transport of these sugars into the Golgi by SLC35E1 is a critical step in maintaining the flow of substrates for continuous glycan chain elongation and modification. GDP-Fucose, another activator, is used in fucosylation reactions, and its transport by SLC35E1 is vital for the modification of glycoproteins. Additionally, the presence of nucleotide compounds such as UTP and ADP-Ribose can activate SLC35E1. UTP is involved in the synthesis of UDP-sugars, and its increased levels may signal the need for enhanced transport activity of SLC35E1. Furthermore, ADP-Ribose, involved in DNA repair and other cellular functions, may also activate SLC35E1 to facilitate the transport of nucleotide sugars necessary for post-translational modifications. The coordinated action of SLC35E1 in response to the presence of these chemicals ensures a regulated supply of crucial substrates for the glycosylation processes within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Clonidine

4205-90-7sc-501519
100 mg
$240.00
1
(0)

CMP-Neu5Ac is a cytidine monophosphate-activated derivative of sialic acid and serves as a substrate for sialyltransferases. SLC35E1, being involved in the transport of nucleotide sugars, could be functionally activated in response to increased intracellular levels of CMP-Neu5Ac to facilitate its translocation for glycosylation.

UDP-α-D-Galactose disodium salt

137868-52-1sc-286849
sc-286849A
10 mg
50 mg
$104.00
$198.00
1
(0)

As a precursor for glycosylation, an increase in uridine diphosphate galactose may necessitate an upregulation of nucleotide sugar transporters like SLC35E1 to facilitate its utilization in the Golgi for glycoprotein synthesis.